<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:sbh="https://wiki.synbiohub.org/wiki/Terms/synbiohub#" xmlns:sbol="http://sbols.org/v2#" xmlns:ns0="http://www.w3.org/ns/prov#" xmlns:ns1="http://purl.org/dc/elements/1.1/" xmlns:ns2="http://purl.org/dc/terms/" xmlns:ns3="http://purl.obolibrary.org/obo/">
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_5_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_5_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb9b00111_5_sequence</sbol:displayId>
    <sbol:elements>tcccggtacctcacttgaaccgttgc</sbol:elements>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_6_comp/1">
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbol:displayId>sb9b00111_6_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_6_comp"/>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_6_sequence/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_6_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_6_sequence"/>
    <sbol:displayId>sb9b00111_6_sequence</sbol:displayId>
    <sbol:elements>atcacccgggatgagtcttctaacc</sbol:elements>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:Collection rdf:about="http://examples.org/sb9b00111/1">
    <ns1:subject>M2 R</ns1:subject>
    <ns1:subject>sucrose</ns1:subject>
    <ns2:references>Balannik, V., Carnevale, V., Fiorin, G., Levine, B. G., Lamb, R. A., Klein, M. L., DeGrado, W. F., Pinto, L. H. Functional Studies and Modeling of Pore-Lining Residue Mutants of the Influenza A Virus M2 Ion Channel Biochemistry 2010. 49:696-708.</ns2:references>
    <ns1:publisher>American Chemical
Society</ns1:publisher>
    <ns2:references>Fontana, J., Steven, A. C. At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane J. Virol. 2013. 87:5621-5628.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_8_comp/1"/>
    <ns1:subject>neuraminidase</ns1:subject>
    <ns1:subject>amantadine-</ns1:subject>
    <ns1:subject>HLA</ns1:subject>
    <ns2:references>Rossman, J. S., Jing, X., Leser, G. P., Lamb, R. A. Influenza virus M2 protein mediates ESCRT-independent membrane scission Cell 2010. 142:902-913.</ns2:references>
    <ns2:references>Osterholm, M. T., Kelley, N. S., Sommer, A., Belongia, E. A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis Lancet Infect. Dis. 2012. 12:36-44.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_7_comp/1"/>
    <ns2:references>CDC Presents Updated Estimates of Flu Vaccine Effectiveness for the 2014&#8211;2015 Season | News (Flu), Center for Disease Control. https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm, accessed February 3, 2019.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_6_sequence/1"/>
    <ns1:subject>CD4</ns1:subject>
    <ns1:subject>gentamicin</ns1:subject>
    <ns2:references>Dong, G., Peng, C., Luo, J., Wang, C., Han, L., Wu, B., Ji, G., He, H. Adamantane-Resistant Influenza A Viruses in the World (1902&#8211;2013): Frequency and Distribution of M2 Gene Mutations PLoS One 2015. 10.</ns2:references>
    <ns2:references>Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., Bean, T., Barclay, W., Deeks, J. J., Lalvani, A. Cellular immune correlates of protection against symptomatic pandemic influenza Nat. Med. 2013. 19:1305-1312.</ns2:references>
    <ns1:subject>gold nanoparticle</ns1:subject>
    <ns1:subject>VLP</ns1:subject>
    <ns1:subject>alkaline phosphatase</ns1:subject>
    <sbol:displayId>sb9b00111</sbol:displayId>
    <ns1:subject>NA</ns1:subject>
    <ns1:subject>M2 gene</ns1:subject>
    <ns1:subject>DH10Bac cells</ns1:subject>
    <ns1:subject>CD8</ns1:subject>
    <ns2:references>Mulvania, T., Hayes, B., Hedin, D. Vol 3, No 3 (2004) - A Flow Cytometric Assay for Rapid, Accurate Determination of Baculovirus Titers BioProcess. J. 2004. 3:47-53.</ns2:references>
    <ns1:subject>H1M1M2-</ns1:subject>
    <ns2:references>Kumar, A., Meldgaard, T. S., Bertholet, S. Novel Platforms for the Development of a Universal Influenza Vaccine Front. Immunol. 2018. 9.</ns2:references>
    <ns2:references>Hill, B. D., Zak, A., Khera, E., Wen, F. Engineering Virus-like Particles for Antigen and Drug Delivery Curr. Protein Pept. Sci. 2017. 19:112-127.</ns2:references>
    <ns2:references>Fernandes, F., Teixeira, A. P., Carinhas, N., Carrondo, M. J., Alves, P. M. Insect cells as a production platform of complex virus-like particles Expert Rev. Vaccines 2013. 12:225-236.</ns2:references>
    <ns2:references>Yee, C. M., Zak, A. J., Hill, B. D., Wen, F. The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics Ind. Eng. Chem. Res. 2018. 57:10061-10070.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_2_sequence/1"/>
    <ns1:subject>MDCK cells</ns1:subject>
    <ns1:subject>insect</ns1:subject>
    <ns1:subject>M2 R ion channel</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_1_comp/1"/>
    <ns2:references>Sakaguchi, T., Leser, G. P., Lamb, R. A. The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus J. Cell Biol. 1996. 133:733-747.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_10_comp/1"/>
    <ns1:subject>Amantadine</ns1:subject>
    <ns2:references>Tutykhina, I., Esmagambetov, I., Bagaev, A., Pichugin, A., Lysenko, A., Shcherbinin, D., Sedova, E., Logunov, D., Shmarov, M., Ataullakhanov, R., Naroditsky, B., Gintsburg, A. Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts PLoS One 2018. 13.</ns2:references>
    <ns2:references>Rossman, J. S., Lamb, R. A. Influenza virus assembly and budding Virology 2011. 411:229-236.</ns2:references>
    <ns1:subject>influenza virus-like
particle (VLP)</ns1:subject>
    <ns2:references>Kozakov, D., Chuang, G.-Y., Beglov, D., Vajda, S. Where does amantadine bind to the influenza virus M2 proton channel? Trends Biochem. Sci. 2010. 35:471-475.</ns2:references>
    <ns1:subject>H1M1M2</ns1:subject>
    <ns2:references>Alavi-Esfahani, M., Fotouhi-Chahooki, F., Saleh, M., Tavakoli, R., Farahmand, B., Ghaemi, A., Tavassoti-Kheiri, M. Over Expression of Influenza Virus M2 Protein in Prokaryotic System Iran. J. Virol. 2012. 6:13-19.</ns2:references>
    <ns2:references>Henkel, J. R., Weisz, O. A. Influenza virus M2 protein slows traffic along the secretory pathway. pH perturbation of acidified compartments affects early Golgi transport steps J. Biol. Chem. 1998. 273:6518-6524.</ns2:references>
    <ns1:subject>mammalian cell lines</ns1:subject>
    <ns1:subject>amino acids</ns1:subject>
    <ns2:references>Johansson, M., Ieong, K.-W., Trobro, S., Strazewski, P., &#197;qvist, J., Pavlov, M. Y., Ehrenberg, M. pH-sensitivity of the ribosomal peptidyl transfer reaction dependent on the identity of the A-site aminoacyl-tRNA Proc. Natl. Acad. Sci. U. S. A. 2011. 108:79-84.</ns2:references>
    <ns2:isPartOf>ACS Synthetic Biology</ns2:isPartOf>
    <ns1:subject>Madin&#8211;Darby Canine Kidney (MDCK) cells</ns1:subject>
    <ns1:subject>XhoI</ns1:subject>
    <ns1:subject>H1M1-</ns1:subject>
    <ns2:references>Watanabe, I., Zhu, J., Recio-Pinto, E., Thornhill, W. B. The Degree of N-glycosylation Affects the Trafficking and Cell Surface Expression Levels of Kv1.4 Potassium Channels J. Membr. Biol. 2015. 248:187-196.</ns2:references>
    <ns2:dateSubmitted>2019-03-15</ns2:dateSubmitted>
    <ns2:references>Ross, K. A., Huntimer, L. M., Vela
Ramirez, J. E., Adams, J. R., Carpenter, S. L., Kohut, M. L., Bronich, T., Webby, R., Legge, K. L., Mallapragada, S. K., Wannemuehler, M. J., Narasimhan, B. Vaccine Technologies Against Avian Influenza: Current Approaches and New Directions J. Biomed. Nanotechnol. 2014. 10:2261-2294.</ns2:references>
    <ns1:subject>matrix protein M2</ns1:subject>
    <ns2:references>Reynders, E., Foulquier, F., Annaert, W., Matthijs, G. How Golgi glycosylation meets and needs trafficking: the case of the COG complex Glycobiology 2011. 21:853-863.</ns2:references>
    <ns2:references>Fiers, W., De Filette, M., Birkett, A., Neirynck, S., Min Jou, W. A &#8220;universal&#8221; human influenza A vaccine Virus Res. 2004. 103:173-176.</ns2:references>
    <ns1:subject>KpnI</ns1:subject>
    <ns1:subject>GP64</ns1:subject>
    <ns2:references>Raeeszadeh-Sarmazdeh, M., Hartzell, E., Price, J. V., Chen, W. Protein nanoparticles as multifunctional biocatalysts and health assessment sensors Curr. Opin. Chem. Eng. 2016. 13:109-118.</ns2:references>
    <ns2:references>Figliozzi, R. W., Chen, F., Chi, A., Hsia, S.-C. V. Using the inverse Poisson distribution to calculate multiplicity of infection and viral replication by a high-throughput fluorescent imaging system Virol. Sin. 2016. 31:180-183.</ns2:references>
    <ns1:subject>Baculovirus</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_5_sequence/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_10_sequence/1"/>
    <ns1:subject>WT baculovirus-infected cells</ns1:subject>
    <ns2:references>Guinea, R., Carrasco, L. Influenza virus M2 protein modifies membrane permeability in E. coli cells FEBS Lett. 1994. 343:242-246.</ns2:references>
    <ns2:references>Kurtz, S., Luo, G., Hahnenberger, K. M., Brooks, C., Gecha, O., Ingalls, K., Numata, K., Krystal, M. Growth impairment resulting from expression of influenza virus M2 protein in Saccharomyces cerevisiae: identification of a novel inhibitor of influenza virus Antimicrob. Agents Chemother. 1995. 39:2204-2209.</ns2:references>
    <ns2:references>Leser, G. P., Lamb, R. A. Lateral Organization of Influenza Virus Proteins in the Budozone Region of the Plasma Membrane J. Virol. 2017. 91.</ns2:references>
    <ns1:subject>antigen density</ns1:subject>
    <ns2:references>Mun&#771;oz-Medina, J.
E., Sa&#769;nchez-Vallejo, C. J., Me&#769;ndez-Tenorio, A., Monroy-Mun&#771;oz, I. E., Angeles-Marti&#769;nez, J., Santos Coy-Arechavaleta, A., Santacruz-Tinoco, C. E., Gonza&#769;lez-Ibarra, J., Anguiano-Herna&#769;ndez, Y.-M., Gonza&#769;lez-Bonilla, C. R., Ramo&#769;n-Gallegos, E., Di&#769;az-Quin&#771;onez, J. A. In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential BioMed Res. Int. 2015. 2015.</ns2:references>
    <ns2:references>Gonza&#769;lez-Galarza, F. F., Takeshita, L. Y. C., Santos, E. J. M., Kempson, F., Maia, M. H. T., Silva, A. L. S. da, Silva, A. L. T. e, Ghattaoraya, G. S., Alfirevic, A., Jones, A. R., Middleton, D. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations Nucleic Acids Res. 2015. 43:D784-D788.</ns2:references>
    <ns1:subject>DRB1*04</ns1:subject>
    <ns1:subject>Sf9 cell</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_1_sequence/1"/>
    <ns1:subject>CRL-1711</ns1:subject>
    <ns1:subject>mice</ns1:subject>
    <ns2:references>Wong, S.-S., Webby, R. J. Traditional and new influenza vaccines Clin. Microbiol. Rev. 2013. 26:476-492.</ns2:references>
    <ns1:subject>M2 matrix protein</ns1:subject>
    <ns2:references>Clemens, E., van de Sandt, C., Wong, S., Wakim, L., Valkenburg, S. Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine Vaccines 2018. 6.</ns2:references>
    <ns1:subject>XmaI</ns1:subject>
    <ns1:subject>A*11</ns1:subject>
    <ns1:subject>HA</ns1:subject>
    <ns1:subject>Tubulin</ns1:subject>
    <ns1:subject>H1M1</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_2_comp/1"/>
    <ns2:references>Yang, D.-G., Chung, Y.-C., Lai, Y.-K., Lai, C.-W., Liu, H.-J., Hu, Y.-C. Avian Influenza Virus Hemagglutinin Display on Baculovirus Envelope: Cytoplasmic Domain Affects Virus Properties and Vaccine Potential Mol. Ther. 2007. 15:989-996.</ns2:references>
    <ns2:references>Klausberger, M., Tscheliessnig, R., Neff, S., Nachbagauer, R., Wohlbold, T. J., Wilde, M., Palmberger, D., Krammer, F., Jungbauer, A., Grabherr, R. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus PLoS One 2016. 11.</ns2:references>
    <ns2:references>Wang, J., Wu, Y., Ma, C., Fiorin, G., Wang, J., Pinto, L. H., Lamb, R. A., Klein, M. L., Degrado, W. F. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus Proc. Natl. Acad. Sci. U. S. A. 2013. 110:1315-1320.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_3_comp/1"/>
    <ns1:subject>Sf9 cells</ns1:subject>
    <ns1:creator>Andrew J. Zak</ns1:creator>
    <ns1:subject>M2 Ion Channel</ns1:subject>
    <ns1:subject>penicillin</ns1:subject>
    <ns1:subject>hemagglutinin</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_7_sequence/1"/>
    <ns2:references>Li, S., Sieben, C., Ludwig, K., Ho&#776;fer, C. T., Chiantia, S., Herrmann, A., Eghiaian, F., Schaap, I. A. T. pH-Controlled Two-Step Uncoating of Influenza Virus Biophys. J. 2014. 106:1447-1456.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_8_sequence/1"/>
    <ns1:creator>Syed M. Rizvi</ns1:creator>
    <ns1:type>research-article</ns1:type>
    <ns1:subject>WT-</ns1:subject>
    <ns1:subject>AvrII</ns1:subject>
    <ns1:creator>Madeleine Yang</ns1:creator>
    <ns1:subject>H1M1M2-infected Sf9 cells</ns1:subject>
    <ns1:subject>H1M1-infected cells</ns1:subject>
    <ns1:subject>IgG</ns1:subject>
    <ns2:references>Huang, M., Huang, W., Wen, F., Larson, R. G. Efficient estimation of binding free energies between peptides and an MHC class II molecule using coarse-grained molecular dynamics simulations with a weighted histogram analysis method J. Comput. Chem. 2017. 38:2007-2019.</ns2:references>
    <ns1:subject>amantadine</ns1:subject>
    <ns2:description>To provide broader protection and eliminate the need for annual update of influenza vaccines, biomolecular engineering of influenza virus-like particles (VLPs) to display more conserved influenza proteins such as the matrix protein M2 has been explored. However, achieving high surface density of full-length M2 in influenza VLPs has been left unrealized. In this study, we show that the ion channel activity of M2 induces significant cytopathic effects in Spodoptera frugiperda (Sf9) insect cells when expressed using M2-encoding baculovirus. These effects include altered Sf9 cell morphology and reduced baculovirus replication, resulting in impaired influenza protein expression and thus VLP production. On the basis of the function of M2, we hypothesized that blocking its ion channel activity could potentially relieve these cytopathic effects, and thus restore influenza protein expression to improve VLP production. The use of the M2 inhibitor amantadine indeed improves Sf9 cellular expression not only of M2 (&#8764;3-fold), but also of hemagglutinin (HA) (&#8764;7-fold) and of matrix protein M1 (&#8764;3-fold) when coexpressed to produce influenza VLPs. This increased cellular expression of all three influenza proteins further leads to &#8764;2-fold greater VLP yield. More importantly, the quality of the resulting influenza VLPs is significantly improved, as demonstrated by the &#8764;2-fold, &#8764;50-fold, and &#8764;2-fold increase in the antigen density to approximately 53 HA, 48 M1, and 156 M2 per influenza VLP, respectively. Taken together, this study represents a novel approach to enable the efficient incorporation of full-length M2 while enhancing both the yield and quality of influenza VLPs produced by Sf9 cells.</ns2:description>
    <ns1:subject>H1M1M2 R-and H1M1M2-infected cells</ns1:subject>
    <ns1:subject>M1</ns1:subject>
    <ns1:subject>HA and M2 R</ns1:subject>
    <ns2:references>Sui, J., Sheehan, J., Hwang, W. C., Bankston, L. A., Burchett, S. K., Huang, C.-Y., Liddington, R. C., Beigel, J. H., Marasco, W. A. Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies Clin. Infect. Dis. 2011. 52:1003-1009.</ns2:references>
    <ns2:references>Arevalo, M. T., Wong, T. M., Ross, T. M. Expression and Purification of Virus-like Particles for Vaccination J. Visualized Exp. 2016.</ns2:references>
    <ns1:subject>PTA</ns1:subject>
    <ns1:subject>Manassas</ns1:subject>
    <ns1:subject>gold nanoparticles</ns1:subject>
    <ns1:subject>HindIII</ns1:subject>
    <ns2:rightsHolder>American Chemical
Society</ns2:rightsHolder>
    <sbol:version>1</sbol:version>
    <ns2:references>Ilyinskii, P. O., Gabai, V. L., Sunyaev, S. R., Thoidis, G., Shneider, A. M. Toxicity of Influenza A Virus Matrix Protein 2 for Mammalian Cells is Associated with its Intrinsic Proton-Channeling Activity Cell Cycle 2007. 6:2043-2047.</ns2:references>
    <ns2:references>Margine, I., Palese, P., Krammer, F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system J. Visualized Exp. 2013.</ns2:references>
    <ns1:subject>H1M1M2 R-</ns1:subject>
    <ns2:references>Scheiffele, P., Fu&#776;llekrug, J. Glycosylation and protein transport Essays Biochem. 2000. 36:27-35.</ns2:references>
    <ns2:references>Kirkpatrick, E., Qiu, X., Wilson, P. C., Bahl, J., Krammer, F. The influenza virus hemagglutinin head evolves faster than the stalk domain Sci. Rep. 2018. 8.</ns2:references>
    <ns1:subject>Sf9 Cells</ns1:subject>
    <ns1:subject>glycerol.</ns1:subject>
    <ns2:references>Lu, Y., Welsh, J. P., Swartz, J. R. Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines Proc. Natl. Acad. Sci. U. S. A. 2014. 111:125-130.</ns2:references>
    <ns1:subject>H1M1M2-and H1M1M2 R-infected Sf9 cells</ns1:subject>
    <ns1:subject>. Amantadine</ns1:subject>
    <ns1:subject>cells</ns1:subject>
    <ns2:references>Skowronski, D. M., De Serres, G., Crowcroft, N. S., Janjua, N. Z., Boulianne, N., Hottes, T. S., Rosella, L. C., Dickinson, J. A., Gilca, R., Sethi, P., Ouhoummane, N., Willison, D. J., Rouleau, I., Petric, M., Fonseca, K., Drews, S. J., Rebbapragada, A., Charest, H., Hamelin, M.-E., Boivin, G., Gardy, J. L., Li, Y., Kwindt, T. L., Patrick, D. M., Brunham, R. C. Association between the 2008&#8211;09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada PLoS Med. 2010. 7.</ns2:references>
    <ns1:creator>Brett D. Hill</ns1:creator>
    <ns1:subject>HA + M2 + Sf9 cells</ns1:subject>
    <ns1:subject>protein G</ns1:subject>
    <ns1:creator>Mason R. Smith</ns1:creator>
    <ns2:references>Kim, M.-C., Lee, J.-S., Kwon, Y.-M., O, E., Lee, Y.-J., Choi, J.-G., Wang, B.-Z., Compans, R. W., Kang, S.-M. Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection Antiviral Res. 2013. 99:328-335.</ns2:references>
    <ns2:references>Manini, I., Trombetta, C. M., Lazzeri, G., Pozzi, T., Rossi, S., Montomoli, E. Egg-Independent Influenza Vaccines and Vaccine Candidates Vaccines 2017. 5.</ns2:references>
    <ns1:subject>M2</ns1:subject>
    <ns2:title>Enhancing the Yield and Quality of Influenza Virus-like Particles (VLPs) Produced in Insect Cells by Inhibiting Cytopathic Effects of Matrix Protein M2</ns2:title>
    <ns2:references>Kim, M.-C., Song, J.-M., Eunju, O., Kwon, Y.-M., Lee, Y.-J., Compans, R. W., Kang, S.-M. Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus Mol. Ther. 2013. 21:485-492.</ns2:references>
    <ns1:subject>matrix protein M1</ns1:subject>
    <ns1:subject>M2e</ns1:subject>
    <ns1:subject>infected Sf9 cell</ns1:subject>
    <ns1:subject>streptomycin</ns1:subject>
    <ns2:references>Durrant, M. G., Eggett, D. L., Busath, D. D. Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence BMC Genet. 2015. 16.</ns2:references>
    <ns1:subject>M2 protein</ns1:subject>
    <ns2:references>Kim, Y., Ponomarenko, J., Zhu, Z., Tamang, D., Wang, P., Greenbaum, J., Lundegaard, C., Sette, A., Lund, O., Bourne, P. E., Nielsen, M., Peters, B. Immune epitope database analysis resource Nucleic Acids Res. 2012. 40:W525-530.</ns2:references>
    <ns2:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <ns1:subject>baculovirus-infected cells</ns1:subject>
    <ns2:dateCopyrighted>2019</ns2:dateCopyrighted>
    <ns2:references>Black, R. A., Rota, P. A., Gorodkova, N., Cramer, A., Klenk, H.-D., Kendal, A. P. Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine J. Gen. Virol. 1993. 74:1673-1677.</ns2:references>
    <ns2:references>Kim, Y.-J., Lee, Y.-T., Kim, M.-C., Lee, Y.-N., Kim, K.-H., Ko, E.-J., Song, J.-M., Kang, S.-M. Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice Front. Immunol. 2017. 8.</ns2:references>
    <ns2:references>Gotoh, T., Ando, N., Kikuchi, K.-I. Re-Infection Profile of Baculoviruses to Sf-9 Insect Cells that Have Already Been Infected: Virus Binding and Recombinant Protein Production J. Chem. Eng. Jpn. 2008. 41:804-808.</ns2:references>
    <ns1:subject>gentamycin</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_6_comp/1"/>
    <ns2:references>Samji, T. Influenza A: understanding the viral life cycle Yale J. Biol. Med. 2009. 82:153-159.</ns2:references>
    <ns0:wasDerivedFrom rdf:resource="https://pubs.acs.org/doi/10.1021/acssynbio.9b00111"/>
    <ns1:subject>ion channel</ns1:subject>
    <ns2:references>Chen, B. J., Leser, G. P., Jackson, D., Lamb, R. A. The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding J. Virol. 2008. 82:10059-10070.</ns2:references>
    <ns1:subject>Cellfectin II</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_4_comp/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/sb9b00111"/>
    <ns2:references>Rivinoja, A., Pujol, F. M., Hassinen, A., Kellokumpu, S. Golgi pH, its regulation and roles in human disease Ann. Med. 2012. 44:542-554.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_5_comp/1"/>
    <ns2:references>Quan, F.-S., Lee, Y.-T., Kim, K.-H., Kim, M.-C., Kang, S.-M. Progress in developing virus-like particle influenza vaccines Expert Rev. Vaccines 2016. 15:1281-1293.</ns2:references>
    <ns2:references>Wen, F. , Rubin-Pitel, S. B. , and Zhao, H. (2009) Engineering of Therapeutic Proteins, In Protein Engineering and Design ( Park, S. J. , and Cochran, J. R. , Eds.), pp 153&#8211;177, CRC Press.</ns2:references>
    <ns3:OBI_0002110 rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <ns1:subject>kanamycin</ns1:subject>
    <ns1:subject>H1M1-and H1M1M2-infected Sf9 cells</ns1:subject>
    <ns2:references>Zhang, K., Wang, Z., Fan, G.-Z., Wang, J., Gao, S., Li, Y., Sun, L., Yin, C.-C., Liu, W.-J. Two polar residues within C-terminal domain of M1 are critical for the formation of influenza A Virions Cell. Microbiol. 2015. 17:1583-1593.</ns2:references>
    <ns1:subject>P10</ns1:subject>
    <ns1:subject>PR8</ns1:subject>
    <ns2:references>Neumann, G., Noda, T., Kawaoka, Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus Nature 2009. 459:931-939.</ns2:references>
    <ns2:references>Song, J.-M., Wang, B.-Z., Park, K.-M., Van Rooijen, N., Quan, F.-S., Kim, M.-C., Jin, H.-T., Pekosz, A., Compans, R. W., Kang, S.-M. Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity PLoS One 2011. 6.</ns2:references>
    <ns2:references>Fuenmayor, J., Go&#768;dia, F., Cervera, L. Production of virus-like particles for vaccines New Biotechnol. 2017. 39:174-180.</ns2:references>
    <ns2:references>Smith, M. R., Tolbert, S. V., Wen, F. Protein-Scaffold Directed Nanoscale Assembly of T Cell Ligands: Artificial Antigen Presentation with Defined Valency, Density, and Ratio ACS Synth. Biol. 2018. 7:1629-1639.</ns2:references>
    <ns2:abstract>To provide broader protection and eliminate the need for annual update of influenza vaccines, biomolecular engineering of influenza virus-like particles (VLPs) to display more conserved influenza proteins such as the matrix protein M2 has been explored. However, achieving high surface density of full-length M2 in influenza VLPs has been left unrealized. In this study, we show that the ion channel activity of M2 induces significant cytopathic effects in Spodoptera frugiperda (Sf9) insect cells when expressed using M2-encoding baculovirus. These effects include altered Sf9 cell morphology and reduced baculovirus replication, resulting in impaired influenza protein expression and thus VLP production. On the basis of the function of M2, we hypothesized that blocking its ion channel activity could potentially relieve these cytopathic effects, and thus restore influenza protein expression to improve VLP production. The use of the M2 inhibitor amantadine indeed improves Sf9 cellular expression not only of M2 (&#8764;3-fold), but also of hemagglutinin (HA) (&#8764;7-fold) and of matrix protein M1 (&#8764;3-fold) when coexpressed to produce influenza VLPs. This increased cellular expression of all three influenza proteins further leads to &#8764;2-fold greater VLP yield. More importantly, the quality of the resulting influenza VLPs is significantly improved, as demonstrated by the &#8764;2-fold, &#8764;50-fold, and &#8764;2-fold increase in the antigen density to approximately 53 HA, 48 M1, and 156 M2 per influenza VLP, respectively. Taken together, this study represents a novel approach to enable the efficient incorporation of full-length M2 while enhancing both the yield and quality of influenza VLPs produced by Sf9 cells.</ns2:abstract>
    <ns1:subject>A*03</ns1:subject>
    <ns1:subject>Sf9</ns1:subject>
    <ns1:subject>phosphotungstic acid</ns1:subject>
    <ns1:subject>tetracycline.</ns1:subject>
    <ns2:references>Nayak, D. P., Hui, E. K.-W., Barman, S. Assembly and budding of influenza virus Virus Res. 2004. 106:147-165.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_9_sequence/1"/>
    <ns2:references>Ferdinands, J. M., Fry, A. M., Reynolds, S., Petrie, J., Flannery, B., Jackson, M. L., Belongia, E. A. Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011&#8211;12 through 2014&#8211;15 Clin. Infect. Dis. 2016. 64:544-550.</ns2:references>
    <ns2:references>Nachbagauer, R., Krammer, F. Universal influenza virus vaccines and therapeutic antibodies Clin. Microbiol. Infect. 2017. 23:222-228.</ns2:references>
    <ns1:creator>Fei Wen</ns1:creator>
    <ns1:subject>Spodoptera frugiperda (Sf9) insect cells</ns1:subject>
    <ns3:OBI_0001617>31487465</ns3:OBI_0001617>
    <ns2:references>Rey-Carrizo, M., Torres, E., Ma, C., Barniol-Xicota, M., Wang, J., Wu, Y., Naesens, L., DeGrado, W. F., Lamb, R. A., Pinto, L. H., Vazquez, S. 3-Azatetracyclo&#173;[5.2.1.15,8.01,5]&#173;undecane Derivatives: From Wild-Type Inhibitors of the M2 Ion Channel of Influenza A Virus to Derivatives with Potent Activity against the V27A Mutant J. Med. Chem. 2013. 56:9265-9274.</ns2:references>
    <ns2:dateAccepted>2019-09-05</ns2:dateAccepted>
    <ns1:subject>WT</ns1:subject>
    <ns2:isPartOf rdf:resource="http://pubs.acs.org/journal/asbcd6"/>
    <ns1:subject>XbaI</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_9_comp/1"/>
    <ns2:references>Kolpe, A., Schepens, B., Fiers, W., Saelens, X. M2-based influenza vaccines: recent advances and clinical potential Expert Rev. Vaccines 2017. 16:123-136.</ns2:references>
    <ns2:references>WHO (2018) Influenza (Seasonal), World Health Organization, Geneva. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal), accessed February 3, 2019.</ns2:references>
    <ns1:subject>E. coli</ns1:subject>
    <ns2:references>Altman, M.
O., Angeletti, D., Yewdell, J. W. Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift Viral Immunol. 2018. 31:142-149.</ns2:references>
    <ns2:created>2019-09-05</ns2:created>
    <ns1:subject>H1M1M2-infected cells</ns1:subject>
    <ns2:references>Terajima, M., Babon, J., Co, M., Ennis, F. A. Cross-reactive human B cell and T cell epitopes between influenza A and B viruses Virol. J. 2013. 10.</ns2:references>
    <ns2:references>Geisler, C., Mabashi-Asazuma, H., Jarvis, D. L.  Methods Mol. Biol. 2015. 1321:131-152.</ns2:references>
    <ns2:references>Wilkinson, T. M., Li, C. K. F., Chui, C. S. C., Huang, A. K. Y., Perkins, M., Liebner, J. C., Lambkin-Williams, R., Gilbert, A., Oxford, J., Nicholas, B., Staples, K. J., Dong, T., Douek, D. C., McMichael, A. J., Xu, X.-N. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans Nat. Med. 2012. 18:274-280.</ns2:references>
    <ns1:subject>universal influenza
vaccine</ns1:subject>
    <ns1:subject>Sf9 insect cells</ns1:subject>
    <ns2:references>Veit, M., Thaa, B. Association of influenza virus proteins with membrane rafts Adv. Virol. 2011. 2011.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_3_sequence/1"/>
    <ns1:subject>M2 ion channel</ns1:subject>
    <ns1:subject>human</ns1:subject>
    <ns1:subject>glycosylation</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb9b00111_4_sequence/1"/>
    <ns1:subject>yeast</ns1:subject>
  </sbol:Collection>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_4_comp/1">
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_4_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_4_sequence/1"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:displayId>sb9b00111_4_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_8_sequence/1">
    <sbol:displayId>sb9b00111_8_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_8_sequence"/>
    <sbol:elements>atcacccgggatgagtcttctaaccga</sbol:elements>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_8_comp/1">
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_8_comp"/>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_8_sequence/1"/>
    <sbol:displayId>sb9b00111_8_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_10_comp/1">
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:displayId>sb9b00111_10_comp</sbol:displayId>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_10_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_10_sequence/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:version>1</sbol:version>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_1_comp/1">
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_1_comp"/>
    <sbol:displayId>sb9b00111_1_comp</sbol:displayId>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_1_sequence/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_3_sequence/1">
    <sbol:displayId>sb9b00111_3_sequence</sbol:displayId>
    <sbol:elements>aatctagaatgaaggcaaacctactggtcc</sbol:elements>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_3_sequence"/>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_10_sequence/1">
    <sbol:elements>atcacccgggatgagtcttctaaccga</sbol:elements>
    <sbol:displayId>sb9b00111_10_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_10_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_2_comp/1">
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_2_sequence/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_2_comp"/>
    <sbol:displayId>sb9b00111_2_comp</sbol:displayId>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_3_comp/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_3_comp"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb9b00111_3_comp</sbol:displayId>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_3_sequence/1"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:version>1</sbol:version>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_9_sequence/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_9_sequence"/>
    <sbol:elements>atggctcgagttactccagctctatgc</sbol:elements>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb9b00111_9_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_5_comp/1">
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_5_sequence/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:displayId>sb9b00111_5_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_5_comp"/>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_4_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_4_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb9b00111_4_sequence</sbol:displayId>
    <sbol:elements>acaagctttcagatgcatattctgcactgc</sbol:elements>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_9_comp/1">
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbol:displayId>sb9b00111_9_comp</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_9_comp"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_9_sequence/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_7_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>atggctcgagttactccagctctatgc</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_7_sequence"/>
    <sbol:displayId>sb9b00111_7_sequence</sbol:displayId>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_2_sequence/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_2_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>gcaagatcccaatgatacttgcggcaataacgagaggatcacttgaaccg</sbol:elements>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb9b00111_2_sequence</sbol:displayId>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb9b00111_1_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>cggttcaagtgatcctctcgttattgccgcaagtatcattgggatcttgc</sbol:elements>
    <sbol:displayId>sb9b00111_1_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb9b00111_1_sequence"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb9b00111_7_comp/1">
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/sb9b00111/suppl/sb-2019-00111y_si_001.pdf"/>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:displayId>sb9b00111_7_comp</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb9b00111_7_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb9b00111_7_sequence/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.9b00111"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
  </sbol:ComponentDefinition>
</rdf:RDF>
